1. Home
  2. SLN vs CRGO Comparison

SLN vs CRGO Comparison

Compare SLN & CRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Silence Therapeutics Plc American Depository Share

SLN

Silence Therapeutics Plc American Depository Share

N/A

Current Price

$6.85

Market Cap

236.2M

Sector

Health Care

ML Signal

N/A

Logo Freightos Limited Ordinary shares

CRGO

Freightos Limited Ordinary shares

N/A

Current Price

$1.26

Market Cap

195.4M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
SLN
CRGO
Founded
1994
2012
Country
United Kingdom
Spain
Employees
116
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
236.2M
195.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SLN
CRGO
Price
$6.85
$1.26
Analyst Decision
Buy
Analyst Count
5
0
Target Price
$42.60
N/A
AVG Volume (30 Days)
195.9K
142.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$10.61
Revenue Next Year
N/A
$16.85
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.97
$1.17
52 Week High
$7.78
$4.24

Technical Indicators

Market Signals
Indicator
SLN
CRGO
Relative Strength Index (RSI) 71.58 29.14
Support Level $5.79 N/A
Resistance Level $7.40 $2.51
Average True Range (ATR) 0.57 0.15
MACD 0.17 -0.01
Stochastic Oscillator 90.33 7.44

Price Performance

Historical Comparison
SLN
CRGO

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.

About CRGO Freightos Limited Ordinary shares

Freightos Ltd operates as a vendor-neutral booking and payment platform for international freight. Its platform supports supply chain efficiency and agility by enabling real-time procurement of ocean and air shipping across more than ten thousand importers/exporters. forwarders, and dozens of airlines and ocean carriers. WebCargo by Freightos is a freight platform connecting carriers and forwarders in particular an air cargo eBooking platform. Freightos.com is a digital international freight marketplace for importers and exporters for instant pricing, booking, and shipment management. The company operates in two segments-Platform segment and Solutions segment. Geographically, the company operates in Europe, Hong Kong, United States which is majority revenue generator and others.

Share on Social Networks: